reports
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Confere...
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate in a Formal Presentation at 4:30 p.m. Pacific Time. A live webcast of the presentation will be accessi...
Mesa Laboratories, Inc. to Announce Third Quarter Results on February ...
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026 LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, February 3, 2026. About Mesa LaboratoriesMesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and se...
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conference...
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences: Raymond James Napa Valley Small Cap SymposiumFormat: 1x1 Meetings Date: Monday, November 17, 2025Jefferies London Healthcare Conference Format: Fireside chatDate: Thursday, November 20, 2025Time: 12:00 p.m. GMTWebcast: 8th Annual Evercore Healthcare ConferenceFormat: Fireside chat Date: Wednesday, Decemb...
Mesa Labs Announces Second Quarter Results
Mesa Labs Announces Second Quarter Results LAKEWOOD, Colo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q26”) ended September 30, 2025 (amounts in thousands). Financial Summary – 2Q26 versus the same year ago period Revenues increased 5.0%Non-GAAP core organic revenues1 growth was 3.7%Operating income increased 34.7% to $4,724 Non-GAAP adjusted operating income (“AOI”) e...
Mesa Laboratories, Inc. to Announce Second Quarter Results on November...
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025 LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help...
MESA LABS DECLARES QUARTERLY DIVIDEND
MESA LABS DECLARES QUARTERLY DIVIDEND Lakewood, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2025, to shareholders of record at the close of business on November 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the p...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
HRTG HERITAGE INSURANCE HOLDINGS INC.
GNW GENWORTH FINANCIAL INC. CLASS A
CIA CITIZENS INC. CL A
BTU PEABODY ENERGY CORPORATION
ARCT ARCTURUS THERAPEUTICS HOLDINGS INC
CRNC CERENCE
EVI EVI INDUSTRIES
MASS 908 DEVICES
LMND LEMONADE INC
SOFI SOFI TECHNOLOGIES INC
ASTS AST SPACEMOBILE INC
JOBY JOBY AVIATION INC
RGTI RIGETTI COMPUTING INC
ERY DIREXION DAILY ENERGY BEAR 3X SHARES
MPTI M TRON INDUSTRIES INC
KYTX KYVERNA THERAPEUTICS INC
UMAC UNUSUAL MACHS INC NEV
BKSY BLACKSKY TECHNOLOGY INC
DGNX DIGINEX LIMITED
AEVA AEVA TECHNOLOGIES INC.
FATN FATPIPE INC
PRE PRENETICS GLOBAL LIMITED
FMFC KANDAL M VENTURE LTD
PSKY PARAMOUNT SKYDANCE CORPORATION
BETR BETTER HOME & FINANCE HOLDING COMPANY
TIC ACUREN CORPORATION
Mesa Laboratories Executes Previously-Announced Strategic Financing Pl...
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company’s 1.375% Convertible Senior Notes due August 2025 (the “2025 Notes”). On August 12, 2025, the Company drew $97.0 million under its existing Amended and Restated Credit Agreement (the “Credit Agreement”), bringing the total outstanding balance to $108...
Mesa Labs Announces First Quarter Results
Mesa Labs Announces First Quarter Results LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q26”) ended June 30, 2025 (amounts in thousands). First quarter FY26 compared to first quarter FY25: Revenues increased 2.4%Non-GAAP core organic revenues1 growth was 0.4% Operating income decreased 45.1% to $3,064 primarily due to the impacts of FX and non-cash stock-based compensation ...
MESA LABS DECLARES QUARTERLY DIVIDEND
MESA LABS DECLARES QUARTERLY DIVIDEND LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the p...
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5,...
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025 LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and servic...
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q25”) and full fiscal year (“FY25”) ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,469Non-GAA...
MESA LABS DECLARES QUARTERLY DIVIDEND
MESA LABS DECLARES QUARTERLY DIVIDEND LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmace...
Mesa Labs Announces Third Quarter Results
Mesa Labs Announces Third Quarter Results LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q25”) ended December 31, 2024 (amounts in thousands). Third quarter FY 2025 compared to third quarter FY 2024: Revenues increased 17.5%Non-GAAP core organic revenues1 increase was 13.2%Operating income increased 8,725% to $5,779Non-GAAP adjusted operating income excluding unusual items2 incre...
Mesa Laboratories, Inc. to Announce Third Quarter Results on February ...
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025 LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern time on Tuesday, February 4, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and s...
Mesa Labs Announces Second Quarter Results
Mesa Labs Announces Second Quarter Results LAKEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q25”) ended September 30, 2024 (amounts in thousands). Second quarter FY 2025 compared to second quarter FY 2024: Revenues increased 8.8%Non-GAAP core organic revenues¹ decline was 2.8%Operating income increased 5,947% to $3,508 Non-GAAP adjusted operating income excluding unusual items² increa...
MESA LABS DECLARES QUARTERLY DIVIDEND
MESA LABS DECLARES QUARTERLY DIVIDEND LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the ...
- Dave Nicoski
- Ross LaDuke
ULTA ULTA BEAUTY INC
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MLAB MESA LABORATORIES INC.
KRC KILROY REALTY CORPORATION
HAIN HAIN CELESTIAL GROUP INC.
GDOT GREEN DOT CORPORATION CLASS A
FIVE FIVE BELOW INC.
EXPE EXPEDIA GROUP INC.
EGBN EAGLE BANCORP INC.
CF CF INDUSTRIES HOLDINGS INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
BRKL BROOKLINE BANCORP INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
ALGN ALIGN TECHNOLOGY INC.
WY WEYERHAEUSER COMPANY
DRI DARDEN RESTAURANTS INC.
FMC FMC CORPORATION
THS TREEHOUSE FOODS INC.
TR TOOTSIE ROLL INDUSTRIES INC.
VFC V.F. CORPORATION
ASIX ADVANSIX INC.
PFE PFIZER INC.
CSCO CISCO SYSTEMS INC.
CTVA CORTEVA INC
CPRI CAPRI HOLDINGS LIMITED
GL GLOBE LIFE INC.
ASO ACADEMY SPORTS AND OUTDOORS
CZR CAESARS ENTERTAINMENT INC
CHK CHESAPEAKE ENERGY CORP
NYMT NEW YORK MORTGAGE TRUST INC.
Mesa Laboratories Inc Co: 1 director
A director at Mesa Laboratories Inc Co sold/sold after exercising options 1,499 shares at 125.000USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
Mesa Labs Announces First Quarter Results
Mesa Labs Announces First Quarter Results LAKEWOOD, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q25”) ended June 30, 2024 (amounts in thousands). First quarter FY 2025 compared to first quarter FY 2024: Revenues increased 14.9%Non-GAAP core organic revenues1 growth was 3.0%Operating income increased 940%Non-GAAP adjusted operating income excluding unusual items2 increased 47.0% and was 26.4...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.